XNU4356
Supplement Thoracic Vertebra to New Technology Group 6 with Synthetic Substitute, Mechanically Expandable (Paired), Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | N Bones |
| Operation | U Supplement |
| Body Part | 4 Thoracic Vertebra |
| Approach | 3 Percutaneous |
| Device | 5 Synthetic Substitute, Mechanically Expandable (Paired) |
| Qualifier | 6 New Technology Group 6 |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family describes adding reinforcing material to bone that is still structurally present but weakened, deficient, or at risk of failure, using a New Technology product recognized for performance beyond older bone graft substitutes. Rather than replacing a bone segment outright, the surgeon builds up or strengthens the existing bone in place, often around screws, cages, or at fracture and fusion sites where added support improves the odds of solid healing.
Patients who receive these procedures often have osteoporotic bone, prior failed hardware, or a spinal fusion site judged likely to fail without extra augmentation. The technology involved is usually a bioactive or engineered bone-void filler or coating designed to encourage faster, stronger bone formation than conventional grafting material, which is the basis for its separate New Technology tracking.
Anatomy & Axis Detail
Thoracic Vertebra
A thoracic vertebra, smaller and more rigidly stabilized by the rib cage than its lumbar counterparts, may still develop compression fracture, osteoporotic collapse, or focal bone deficiency requiring reinforcement rather than removal or fusion. Supplementing the vertebral body with a newer-technology biologic or engineered graft material restores structural competence and helps prevent further collapse or kyphotic progression, which is particularly relevant in the thoracic spine because progressive deformity here can affect chest wall mechanics and spinal cord space. The proximity of the thoracic spinal cord, narrower canal diameter relative to the lumbar region, and the segmental vascular supply from the aorta all factor into how the material is delivered and placed. Coding should reflect that the native vertebral body is preserved and augmented, with the specific thoracic level and material identified.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Synthetic Substitute, Mechanically Expandable (Paired)
This synthetic substitute is a spinal implant, most often an interbody device, that expands mechanically once positioned and is placed as a matched pair rather than a single unit. The paired configuration and mechanical expansion mechanism distinguish it from single expandable cages or static, non-expanding synthetic substitutes used in similar fusion procedures. Expansion in place allows restoration of disc height and lordosis through a smaller initial insertion footprint.
Qualifier: New Technology Group 6
This value marks Group 6, the cohort of new technologies added for the 2019-2020 fiscal year. As with every group qualifier in this section, it is a bookkeeping label showing when a technology earned a distinct code rather than a clue to its function, which is conveyed through the accompanying device or substance value. It should not be read as interchangeable with Group 5 or Group 7.
Coding & Documentation
Coding from this family requires the operative note to specify the augmentation product used and confirm that native bone was left intact and reinforced rather than removed, since that distinction separates Supplement from Replacement. Documentation should also make clear the site being reinforced, particularly when the same operative session includes fusion or instrumentation at nearby levels.
The most frequent mistake is coding routine bone graft material under this family when it does not meet the New Technology product criteria; only the specifically approved technologies qualify, and generic autograft or allograft belongs elsewhere. Coders also sometimes miss that Supplement codes here are reported in addition to, not instead of, any fusion codes for the same operative encounter.
Commonly Confused With
It is most often confused with Replacement, and the deciding question is always whether the original bone was removed (Replacement) or kept and reinforced (Supplement). It can also be mistaken for standard bone grafting captured outside the New Technology section, which applies when the material used does not carry the specific technology designation this family requires.